Literature DB >> 3112966

Comparative in-vitro activity of enoxacin against penicillinase- and non-penicillinase-producing Neisseria gonorrhoeae.

M A Shapiro, C L Heifetz, J C Sesnie.   

Abstract

The in-vitro antigonococcal activity of enoxacin was measured by a broth microdilution method. Comparisons were made with five clinically relevant marketed drugs against 23 clinical isolates of Neisseria gonorrhoeae, including several penicillinase producers as well as multiply resistant strains. Results showed that enoxacin possessed potent activity against all organisms tested, with MIC values ranging from less than or equal to 0.013 to 0.05 micrograms/ml.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3112966     DOI: 10.1097/00007435-198704000-00011

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  3 in total

1.  Interpretive criteria and quality control limits for testing susceptibility of Neisseria gonorrhoeae to enoxacin.

Authors:  A L Barry; M A Cohen; J C Sesnie; P C Fuchs; J A Washington; P R Murray; C Baker
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

Review 2.  Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J M Henwood; J P Monk
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

Review 3.  Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infections.

Authors:  S S Patel; C M Spencer
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.